Marked rebound acid hypersecretion after treatment with ranitidine

American Journal of Gastroenterology

Volumn 91, Issue 2, 1996, Pages 355-359

  El Omar, E ^b   Banerjee, S ^b   Wirz, A ^b   Penman, I ^b   Ardill, J E S ^b   McColl, K E L ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN; GASTRIN RELEASING PEPTIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; HELICOBACTER PYLORI; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; REBOUND; STOMACH ACID SECRETION;

ANTI-ULCER AGENTS; BOMBESIN; GASTRIC ACID; GASTRIN-RELEASING PEPTIDE; GASTRINS; GASTROINTESTINAL HORMONES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; PEPTIDES; RANITIDINE; TIME FACTORS;

EID: 0030040756     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Aadland E, Berstad A. Effect of cimetidine on pentagastrin-stimulated gastric acid and pepsin secretion before and after 6 weeks of cimetidine treatment. Scand J Gastroenterol 1978;13:193-7.
2. Festen HP, Tangerman A, Lamers CBH, et al. Effect of treatment with cimetidine for one year on gastrin cell and parietal cell function and sensitivity to cimetidine in patients with duodenal or gastric ulcers. Postgrad Med J 1980;56:698-701.
3. Mohammed R, Holden RJ, Hearns JB, et al. Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin. Gut 1983;24: 61-6.
4. Forrest JAH, Fettes MR, McLoughlin GP, et al. Effect of long-term cimetidine on gastric acid secretion, serum gastrin, and gastric emptying. Gut 1979;20:404-7.
5. Aadland E, Berstad A. Parietal and chief cell sensitivity to histamine and pentagastrin stimulation before and after cimetidine treatment in healthy subjects. Scand J Gastroenterol 1979;14:933-8.
6. Frislid K, Aadland E, Berstad A. Augmented postprandial gastric acid secretion due to exposure to ranitidine in healthy subjects. Scand J Gastroenterol 1986;21:119-22.
7. Fullarton GM, McLauchlan G, MacDonald A, et al. Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist. Gut 1989;30:449-54.
8. Kummer AF, Johnston DA, Marks IN, et al. Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine. Gut 1992;33:175-8.
9. Fullarton GM, MacDonald AMI, McColl KEL. Rebound hypersecretion after H2-antagonist withdrawal: A comparative study with nizatidine, ranitidine and famotidine. Aliment Pharmacol Ther 1991;5: 391-8.
10. Nwokolo CU, Smith JTL, Sawyerr AM, et al. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade. Gut 1991;32:1455-60.
11. El-Omar E, Penman I, Dorrian CA, et al. Eradicating Helicobacter pylori infection lowers gastrin-mediated acid secretion by two thirds in duodenal ulcer patients. Gut 1993;34:1060-5.
12. Ghatei MA, Jung RT, Stevenson JC, et al. Bombesin: Action on gut hormones and calcium in man. J Clin Endocrinol Metab 1981;54: 980-5.
13. Mulholland G, Ardill JES, Fillmore D, et al. Helicobacter pylori-related hypergastrinaemia is due to a selective increase in gastrin-17. Gut 1993;34:757-61.
14. El-Omar EM, Penman ID, Spence E, et al. The GRP test: A new clinical test of acid secretion - reproducibility data. Eur J Gastroenterol Hepatol 1994;6:417-21.
15. Chittajallu RS, Ardill JES, McColl KEL. The degree of hypergastrinaemia induced by Helicobacter pylori is the same in duodenal ulcer patients and asymptomatic volunteers. Eur J Gastroenterol Hepatol 1992;4:49-53.
16. Smith JTL, Pounder RE, Nwokolo CU, et al. Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut 1990;31:522-5.
17. El-Omar E, Wirz A, McColl KEL. Divergent effects of H. pylori on acid secretion. Gut 1995;37(suppl 1):A83.
18. El-Omar E, Penman I, Ardill JES, et al. The exaggerated acid response to GRP in DU patients completely resolves following eradication of H. pylori. Gut 1993;34(suppl 4):S49.
19. El-Omar E, Banerjee S, Penman ID, et al. H. pylori and impaired inhibitory control of gastric acid secretion in DU patients. Gut 1994; 35(suppl 2):S4.
20. Jones DB, Howden CW, Burget DW, et al. Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist. Gut 1988;29:890-3.